(Q44609801)

4 December 2017

title

Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531811

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

19 March 2024

3

Nosratola D Vaziri

1 reference

4 December 2017

Tadashi Sato

1

1 reference

4 December 2017

Kaihui Liang

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://www.kidney-international.org/article/S0085253815495298/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531811

https://api.elsevier.com/content/article/PII:S0085253815495298?httpAccept=text/xml

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

https://api.elsevier.com/content/article/PII:S0085253815495298?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

19 March 2024

1 reference

4 December 2017

volume

64

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1780-1786

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1523-1755.2003.00281.x

4 December 2017

exact match

0 references

cites work

Renal lesions of hyperlipidemic Imai rats: a spontaneous animal model of focal glomerulosclerosis

1

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats

19 March 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Gene expression of lipoprotein lipase in experimental nephrosis

19 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Acquired VLDL receptor deficiency in experimental nephrosis

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis

19 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of hepatic LDL receptor expression in experimental nephrosis

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of VLDL receptor expression in chronic experimental renal failure

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure

19 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Reduced kidney branched chain aminotransferase expression in puromycin aminonucleoside-induced nephrotic syndrome

19 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients

19 March 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.

19 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys

19 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Oral adsorbent ameliorates renal TGF-beta 1 expression in hypercholesterolemic rats

19 March 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Therapeutic Effects of Oral Sorbent in Undialyzed Uremia

19 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats

19 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats

19 March 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Preventive effects of an oral sorbent on nephropathy in rats

19 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats

19 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Role for “uremic toxin” in the progressive loss of intact nephrons in chronic renal failure

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA.

19 March 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of hepatic lipase expression in experimental nephrotic syndrome

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Molecular mechanisms of lipid disorders in nephrotic syndrome

19 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure

19 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00281.X

19 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 December 2017

1037868460

0 references

1 reference